Case report · 10 Aug 2026
Conference abstractPublished 22 Aug 2016
Cadmium induces cell death in SN56 cholinergic neurons from basal forebrain mediated by acetylcholinesterase variants altered expression
Complutense University of Madrid, Spain; Alfonso X University, Spain
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cadmium is a neurotoxin compound which induces cognitive alterations similar to those produced by Alzheimer’s disease (AD). However, the mechanism through which cadmium induces this effect remains unknown. In this regard, we described in a previous work that cadmium induces a more pronounced cell death on cholinergic neurons from basal forebrain. Degeneration of basal forebrain cholinergic neurons, as happens in AD, results in memory deficits attributable to the loss of cholinergic modulation of hippocampal synaptic circuits. Moreover, cadmium induces acetylcholinesterase (AChE) overexpression, which has been related to cell death induction. Moreover, AChE variants alteration has been reported to mediate apoptotic and necrotic cell loss induction of basal forebrain cholinergic neurons and development of AD. According to all above, we hypothesized that cadmium induces the more pronounced cell death on basal forebrain cholinergic neurons through alteration of AChE variants expression alteration. The present study is aimed at researching the mechanisms of cell death induced by cadmium on basal forebrain cholinergic neurons. For this purpose, we evaluated, in SN56 cholinergic murine septal cell line from basal forebrain region, the cadmium toxic effects on neuronal viability through AChE splice variants. This study proves that cadmium induces cell death on cholinergic neurons through overexpression of tetrameric AChE-S and down-regulation of monomeric AChE-R. Our present results provide new understanding of the mechanisms contributing to the harmful effects of cadmium on cholinergic neurons and suggest that cadmium could mediate this effect through AChE splices altered expression.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Trials.
Short communication · 31 Jul 2026
Understanding Bioavailability as a Key Element in Effective Therapeutic Delivery
Research article · 14 Jun 2026
Ensuring Rights and Dignity in Ethical Practices of Clinical Studies with Vulnerable Group and Safeguarding Vulnerable Group Act (2006)
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Trials
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Javier del Pino”
- BylineArticles whose byline prints “Paula Moyano”
- BylineArticles whose byline prints “Maria Teresa Frejo”
- BylineArticles whose byline prints “Maria Jesus Diaz”
- BylineArticles whose byline prints “Gloria Gomez”
- BylineArticles whose byline prints “Maria Jose Anadon”
- BylineArticles whose byline prints “Margarita Lobo”
- BylineArticles whose byline prints “Jimena Garcia”
